The RAND study revealed confusion among veterans about the VA's policies regarding psychedelics.
The increasing evidence for the therapeutic potential of psychedelics, coupled with growing public and veteran interest, is pushing legislative and medical bodies to re-evaluate their stance.
This data highlights a significant demand for alternative mental health treatments within a critical population and points to potential shifts in healthcare policy and drug regulation.
The study quantifies the scale of psychedelic use among veterans and underscores the VA's policy confusion, indicating a growing pressure for formalized and accessible psychedelic-assisted therapies.
- · Psychedelic therapy developers
- · Mental health advocacy groups
- · Veterans seeking alternative treatments
- · Traditional pharmaceutical companies (in certain mental health segments)
- · VA's current reactive policy framework
Increased advocacy and legislative efforts to decriminalize or legalize psychedelics for therapeutic use will follow.
Psychedelic-assisted therapy could become a mainstream and regulated treatment option for conditions like PTSD, fundamentally altering mental healthcare paradigms.
This could lead to a broader societal re-evaluation of drug scheduling and perceptions of 'illicit' substances, impacting public health and justice systems globally.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at Navy Times